Cardiff Oncology, Inc. (CRDF)
NASDAQ: CRDF · Real-Time Price · USD
1.250
+0.040 (3.31%)
Jun 26, 2026, 4:00 PM EDT - Market closed
Cardiff Oncology Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Cardiff Oncology stock have an average target of 6.00, with a low estimate of 2.00 and a high estimate of 12. The average target predicts an increase of 380.00% from the current stock price of 1.25.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Cardiff Oncology stock from 8 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 6 | 6 | 6 | 6 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 8 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lucid Capital | Lucid Capital | Buy Maintains $10 → $4 | Buy | Maintains | $10 → $4 | +220.00% | Jun 5, 2026 |
| TD Cowen | TD Cowen | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Jun 4, 2026 |
| William Blair | William Blair | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jun 3, 2026 |
| Craig-Hallum | Craig-Hallum | Hold Downgrades $2 | Hold | Downgrades | $2 | +60.00% | Jun 3, 2026 |
| H.C. Wainwright | H.C. Wainwright | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | Jun 1, 2026 |
Financial Forecast
Revenue This Year
229.56K
from 593.00K
Decreased by -61.29%
Revenue Next Year
189.29K
from 229.56K
Decreased by -17.54%
EPS This Year
-0.69
from -0.69
EPS Next Year
-0.81
from -0.69
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 491,000 | 725,000 | |
| Avg | 229,560 | 189,290 | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -17.2% | 215.8% | |
| Avg | -61.3% | -17.5% | |
| Low | -100.0% | -100.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.56 | -0.69 | |
| Avg | -0.69 | -0.81 | |
| Low | -0.78 | -0.86 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.